"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 16 | 9 | 25 |
| 1996 | 18 | 10 | 28 |
| 1997 | 30 | 15 | 45 |
| 1998 | 29 | 9 | 38 |
| 1999 | 42 | 13 | 55 |
| 2000 | 49 | 18 | 67 |
| 2001 | 47 | 14 | 61 |
| 2002 | 49 | 28 | 77 |
| 2003 | 51 | 32 | 83 |
| 2004 | 61 | 26 | 87 |
| 2005 | 48 | 40 | 88 |
| 2006 | 29 | 24 | 53 |
| 2007 | 33 | 22 | 55 |
| 2008 | 29 | 20 | 49 |
| 2009 | 32 | 21 | 53 |
| 2010 | 32 | 25 | 57 |
| 2011 | 25 | 21 | 46 |
| 2012 | 29 | 26 | 55 |
| 2013 | 32 | 31 | 63 |
| 2014 | 26 | 38 | 64 |
| 2015 | 34 | 22 | 56 |
| 2016 | 33 | 26 | 59 |
| 2017 | 28 | 28 | 56 |
| 2018 | 28 | 15 | 43 |
| 2019 | 21 | 27 | 48 |
| 2020 | 31 | 26 | 57 |
| 2021 | 24 | 22 | 46 |
| 2022 | 9 | 26 | 35 |
| 2023 | 19 | 28 | 47 |
| 2024 | 15 | 15 | 30 |
| 2025 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. Clin Cancer Res. 2025 Feb 17; 31(4):628-638.
-
Integration of multiomic data identifies core-module of inherited-retinal diseases. Hum Mol Genet. 2025 Feb 17; 34(5):454-465.
-
Anaplastic meningioma in a 6-year-old with somatic YAP1::MAML2 fusion and multiple endocrine neoplasia type 4 (MEN4) syndrome. Cancer Genet. 2025 Apr; 292-293:106-110.
-
Frontal lobe intra-axial schwannoma harboring a CHD7::VGLL3 fusion and heterozygous TSC2 p.F1510del mutation in a young child. Mol Biol Rep. 2025 Jan 10; 52(1):112.
-
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/?-CATENIN Pathway in Testosterone-Treated Hypogonadal Men. Biomolecules. 2025 Jan 08; 15(1).
-
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip. Nat Genet. 2025 Jan; 57(1):88-102.
-
Overexpression of ELF3 in the PTEN-deficient lung epithelium promotes lung cancer development by inhibiting ferroptosis. Cell Death Dis. 2024 Dec 18; 15(12):897.
-
Pharmacologic Blockade of a Pioneer Transcription Factor. Cancer Res. 2024 Dec 16; 84(24):4124-4125.
-
MGA-related syndrome: A proposed novel disorder. HGG Adv. 2025 Jan 09; 6(1):100387.
-
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett. 2025 Feb 01; 610:217354.